Report Detail

Pharma & Healthcare Global Wound Care Biologics Market Growth 2019-2024

  • RnM2925226
  • |
  • 11 February, 2019
  • |
  • Global
  • |
  • 164 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Global Wound Care Biologics Market Growth 2019-2024

Table of Contents

    2019-2024 Global Wound Care Biologics Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Wound Care Biologics Consumption 2014-2024
        • 2.1.2 Wound Care Biologics Consumption CAGR by Region
      • 2.2 Wound Care Biologics Segment by Type
        • 2.2.1 Biologic Skin Substitutes
        • 2.2.2 Enzyme Based Formulations
        • 2.2.3 Growth Factors
      • 2.3 Wound Care Biologics Consumption by Type
        • 2.3.1 Global Wound Care Biologics Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Wound Care Biologics Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Wound Care Biologics Sale Price by Type (2014-2019)
      • 2.4 Wound Care Biologics Segment by Application
        • 2.4.1 Acute Wounds
        • 2.4.2 Chronic Wounds
        • 2.4.3 Surgical Wounds
      • 2.5 Wound Care Biologics Consumption by Application
        • 2.5.1 Global Wound Care Biologics Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Wound Care Biologics Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Wound Care Biologics Sale Price by Application (2014-2019)

      3 Global Wound Care Biologics by Players

      • 3.1 Global Wound Care Biologics Sales Market Share by Players
        • 3.1.1 Global Wound Care Biologics Sales by Players (2017-2019)
        • 3.1.2 Global Wound Care Biologics Sales Market Share by Players (2017-2019)
      • 3.2 Global Wound Care Biologics Revenue Market Share by Players
        • 3.2.1 Global Wound Care Biologics Revenue by Players (2017-2019)
        • 3.2.2 Global Wound Care Biologics Revenue Market Share by Players (2017-2019)
      • 3.3 Global Wound Care Biologics Sale Price by Players
      • 3.4 Global Wound Care Biologics Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Wound Care Biologics Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Wound Care Biologics Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Wound Care Biologics by Regions

      • 4.1 Wound Care Biologics by Regions
        • 4.1.1 Global Wound Care Biologics Consumption by Regions
        • 4.1.2 Global Wound Care Biologics Value by Regions
      • 4.2 Americas Wound Care Biologics Consumption Growth
      • 4.3 APAC Wound Care Biologics Consumption Growth
      • 4.4 Europe Wound Care Biologics Consumption Growth
      • 4.5 Middle East & Africa Wound Care Biologics Consumption Growth

      5 Americas

      • 5.1 Americas Wound Care Biologics Consumption by Countries
        • 5.1.1 Americas Wound Care Biologics Consumption by Countries (2014-2019)
        • 5.1.2 Americas Wound Care Biologics Value by Countries (2014-2019)
      • 5.2 Americas Wound Care Biologics Consumption by Type
      • 5.3 Americas Wound Care Biologics Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Wound Care Biologics Consumption by Countries
        • 6.1.1 APAC Wound Care Biologics Consumption by Countries (2014-2019)
        • 6.1.2 APAC Wound Care Biologics Value by Countries (2014-2019)
      • 6.2 APAC Wound Care Biologics Consumption by Type
      • 6.3 APAC Wound Care Biologics Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Wound Care Biologics by Countries
        • 7.1.1 Europe Wound Care Biologics Consumption by Countries (2014-2019)
        • 7.1.2 Europe Wound Care Biologics Value by Countries (2014-2019)
      • 7.2 Europe Wound Care Biologics Consumption by Type
      • 7.3 Europe Wound Care Biologics Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Wound Care Biologics by Countries
        • 8.1.1 Middle East & Africa Wound Care Biologics Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Wound Care Biologics Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Wound Care Biologics Consumption by Type
      • 8.3 Middle East & Africa Wound Care Biologics Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Wound Care Biologics Distributors
      • 10.3 Wound Care Biologics Customer

      11 Global Wound Care Biologics Market Forecast

      • 11.1 Global Wound Care Biologics Consumption Forecast (2019-2024)
      • 11.2 Global Wound Care Biologics Forecast by Regions
        • 11.2.1 Global Wound Care Biologics Forecast by Regions (2019-2024)
        • 11.2.2 Global Wound Care Biologics Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Wound Care Biologics Forecast by Type
      • 11.8 Global Wound Care Biologics Forecast by Application

      12 Key Players Analysis

      • 12.1 Smith & Nephew
        • 12.1.1 Company Details
        • 12.1.2 Wound Care Biologics Product Offered
        • 12.1.3 Smith & Nephew Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Smith & Nephew News
      • 12.2 Organogenesis
        • 12.2.1 Company Details
        • 12.2.2 Wound Care Biologics Product Offered
        • 12.2.3 Organogenesis Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Organogenesis News
      • 12.3 MiMedx
        • 12.3.1 Company Details
        • 12.3.2 Wound Care Biologics Product Offered
        • 12.3.3 MiMedx Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 MiMedx News
      • 12.4 Integra
        • 12.4.1 Company Details
        • 12.4.2 Wound Care Biologics Product Offered
        • 12.4.3 Integra Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Integra News
      • 12.5 Osiris
        • 12.5.1 Company Details
        • 12.5.2 Wound Care Biologics Product Offered
        • 12.5.3 Osiris Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Osiris News
      • 12.6 Derma Sciences, Inc
        • 12.6.1 Company Details
        • 12.6.2 Wound Care Biologics Product Offered
        • 12.6.3 Derma Sciences, Inc Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Derma Sciences, Inc News
      • 12.7 Soluble Systems
        • 12.7.1 Company Details
        • 12.7.2 Wound Care Biologics Product Offered
        • 12.7.3 Soluble Systems Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Soluble Systems News
      • 12.8 Amnio Technology, LLC
        • 12.8.1 Company Details
        • 12.8.2 Wound Care Biologics Product Offered
        • 12.8.3 Amnio Technology, LLC Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Amnio Technology, LLC News
      • 12.9 Medline
        • 12.9.1 Company Details
        • 12.9.2 Wound Care Biologics Product Offered
        • 12.9.3 Medline Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Medline News
      • 12.10 Skye® Biologics
        • 12.10.1 Company Details
        • 12.10.2 Wound Care Biologics Product Offered
        • 12.10.3 Skye® Biologics Wound Care Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Skye® Biologics News
      • 12.11 Alphatec Spine,Inc.
      • 12.12 Pinnacle Transplant Technologies

      13 Research Findings and Conclusion

      Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

      Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

      In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
      North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.

      With the development of medical technology level, more and more companies participate in this industry.

      According to this study, over the next five years the Wound Care Biologics market will register a 10.5% CAGR in terms of revenue, the global market size will reach US$ 4690 million by 2024, from US$ 2580 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Wound Care Biologics business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Wound Care Biologics market by product type, application, key manufacturers and key regions and countries.

      This study considers the Wound Care Biologics value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Biologic Skin Substitutes
      Enzyme Based Formulations
      Growth Factors
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Acute Wounds
      Chronic Wounds
      Surgical Wounds

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Smith & Nephew
      Organogenesis
      MiMedx
      Integra
      Osiris
      Derma Sciences, Inc
      Soluble Systems
      Amnio Technology, LLC
      Medline
      Skye® Biologics 
      Alphatec Spine,Inc.
      Pinnacle Transplant Technologies

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Wound Care Biologics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Wound Care Biologics market by identifying its various subsegments.
      Focuses on the key global Wound Care Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Wound Care Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Wound Care Biologics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.


      Summary:
      Get latest Market Research Reports on Wound Care Biologics . Industry analysis & Market Report on Wound Care Biologics is a syndicated market report, published as Global Wound Care Biologics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Wound Care Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      3,015.36
      4,523.05
      6,030.73
      3,298.42
      4,947.63
      6,596.84
      389,621.64
      584,432.46
      779,243.28
      261,886.18
      392,829.26
      523,772.35
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report